Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/17101300
Conclusion of this study
Curcumin seems to be a promising and safe medication for maintaining remission in patients with quiescent UC. Further studies on curcumin should strengthen our findings.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study